Stimulation of Wnt/β-Catenin Signaling to Improve Bone Development by Naringin via Interacting with AMPK and Akt

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1563-1576

  Wang, Dawei ^a   Ma, Wenpu ^a   Wang, Fu ^a   Dong, Jinlei ^a   Wang, Dan ^b   Sun, Bo ^c   Wang, Bomin ^a,b  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c Shandong Medical Imaging Research Institute   (China)

Author keywords

AMP activated protein kinase (AMPK); Lymphoid enhancer factor (LEF) T cell factor (TCF); Naringin; Protein kinase B (Akt); catenin

Indexed keywords

ADENYLATE KINASE; ALKALINE PHOSPHATASE; AURANTIIN; BETA CATENIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; WNT PROTEIN; FLAVANONE DERIVATIVE; MESSENGER RNA; T CELL FACTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE STRENGTH; CELL NUCLEUS; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; GENE EXPRESSION ASSAY; IN VITRO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THIN LAYER CHROMATOGRAPHY; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; CELL LINE; CHEMISTRY; CITRUS; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; RAT;

CITRUS; MUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BETA CATENIN; BONE DEVELOPMENT; CELL LINE; CITRUS; FEMALE; FLAVANONES; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84936935142     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430319     Document Type: Article

References (56)

1. Riggs BL, Melton LJ, 3rd: Involutional osteoporosis. N Engl J Med 1986;314:1676-1686.
2. Riggs BL, Melton LJ, 3rd: The worldwide problem of osteoporosis: Insights afforded by epidemiology. Bone 1995;17:505S-511S.
3. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a who study group. World Health Organ Tech Rep Ser 1994;843:1-129.
4. Kanis JA, Melton LJ, 3rd, Christiansen C, Johnston CC, Khaltaev N: The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
5. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ: Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985;7:178-208.
6. Kanis JA: Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-1936.
7. Bain G, Muller T, Wang X, Papkoff J: Activated beta-catenin induces osteoblast differentiation of c3h10t1/2 cells and participates in bmp2 mediated signal transduction. Biochem Biophys Res Commun 2003;301:84-91.
8. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S: Bmp-2 controls alkaline phosphatase expression and osteoblast mineralization by a wnt autocrine loop. J Bone Miner Res 2003;18:1842-1853.
9. Hartmann C, Tabin CJ: Dual roles of wnt signaling during chondrogenesis in the chicken limb. Development 2000;127:3141-3159.
10. Chen Y, Chen L, Yin Q, Gao H, Dong P, Zhang X, Kang J: Reciprocal interferences of tnf-alpha and wnt1/ beta-catenin signaling axes shift bone marrow-derived stem cells towards osteoblast lineage after ethanol exposure. Cell Physiol Biochem 2013;32:755-765.
11. Moon RT, Bowerman B, Boutros M, Perrimon N: The promise and perils of wnt signaling through beta-catenin. Science 2002;296:1644-1646.
12. Ruel L, Stambolic V, Ali A, Manoukian AS, Woodgett JR: Regulation of the protein kinase activity of shaggy(zeste-white3) by components of the wingless pathway in drosophila cells and embryos. J Biol Chem 1999;274:21790-21796.
13. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X: Ldl-receptor-related proteins in wnt signal transduction. Nature 2000;407:530-535.
14. Bienz M, Clevers H: Armadillo/beta-catenin signals in the nucleus-proof beyond a reasonable doubt Nat Cell Biol 2003;5:179-182.
15. Kahler RA, Westendorf JJ: Lymphoid enhancer factor-1 and beta-catenin inhibit runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 2003;278:11937-11944.
16. Boyle WJ, Simonet WS, Lacey DL: Osteoclast differentiation and activation. Nature 2003;423:337-342.
17. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC: Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 1992;257:88-91.
18. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H: Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 1998;247:610-615.
19. Mizuno A, Kanno T, Hoshi M, Shibata O, Yano K, Fujise N, Kinosaki M, Yamaguchi K, Tsuda E, Murakami A, Yasuda H, Higashio K: Transgenic mice overexpressing soluble osteoclast differentiation factor (sodf) exhibit severe osteoporosis. J Bone Miner Metab 2002;20:337-344.
20. Lu Y, Zhang C, Bucheli P, Wei D: Citrus flavonoids in fruit and traditional chinese medicinal food ingredients in China. Plant Foods Hum Nutr 2006;61:57-65.
21. Deyhim F, Mandadi K, Faraji B, Patil BS: Grapefruit juice modulates bone quality in rats. J Med Food 2008;11:99-104.
22. Zhang P, Dai KR, Yan SG, Yan WQ, Zhang C, Chen DQ, Xu B, Xu ZW: Effects of naringin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cell. Eur J Pharmacol 2009;607:1-5.
23. Li N, Jiang Y, Wooley PH, Xu Z, Yang SY: Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis. J Orthop Sci 2013;18:478-485.
24. Ang ES, Yang X, Chen H, Liu Q, Zheng MH, Xu J: Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of rankl-induced nf-kappab and erk activation. FEBS Lett 2011;585:2755-2762.
25. Ding S, Hu J, Yang J, Liu L, Huang W, Gu X, Ye Y, Huang L, Liang Y, Chen B, Zhuge Q: The inactivation of jak2/stat3 signaling and desensitization of m1 machr in minimal hepatic encephalopathy (mhe) and the protection of naringin against mhe. Cell Physiol Biochem 2014;34:1933-1950.
26. Pang WY, Wang XL, Mok SK, Lai WP, Chow HK, Leung PC, Yao XS, Wong MS: Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (umr-106) cells. Br J Pharmacol 2010;159:1693-1703.
27. Wong RW, Rabie AB: Effect of naringin on bone cells. J Orthop Res 2006;24:2045-2050.
28. Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH: Naringin-induced bone morphogenetic protein-2 expression via pi3k, akt, c-fos/c-jun and ap-1 pathway in osteoblasts. Eur J Pharmacol 2008;588:333-341.
29. Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK: Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr Rev 2005;26:688-703.
30. Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, Shin YI, Lee MS, Kim HS, Kim JW, Chun CH, Cho HJ, Hong GY, Juhng SK, Yoon KH, Park BH, Bae JM, Han JK, Oh J: Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull 2009;32:1193-1198.
31. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M: Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 1997;186:489-495.
32. Xie F, Wu CF, Lai WP, Yang XJ, Cheung PY, Yao XS, Leung PC, Wong MS: The osteoprotective effect of herba epimedii (hep) extract in vivo and in vitro. Evid Based Complement Alternat Med 2005;2:353-361.
33. Gasser JA, Willnecker J: Bone measurements by peripheral quantitative computed tomography in rodents. Methods Mol Biol 2012;816:477-498.
34. Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS: Improvement of bone properties and enhancement of mineralization by ethanol extract of fructus ligustri lucidi. Br J Nutr 2008;99:494-502.
35. Krishnan V, Bryant HU, Macdougald OA: Regulation of bone mass by wnt signaling. J Clin Invest 2006;116:1202-1209.
36. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y: Wnt-5a inhibits the canonical wnt pathway by promoting gsk-3-independent beta-catenin degradation. J Cell Biol 2003;162:899-908.
37. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W: Functional interaction of an axin homolog, conductin, with beta-catenin, apc, and gsk3beta. Science 1998;280:596-599.
38. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA: Novel mechanism of wnt signalling inhibition mediated by dickkopf-1 interaction with lrp6/arrow. Nat Cell Biol 2001;3:683-686.
39. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P: The f-box protein beta-trcp associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999;9:207-210.
40. Staal FJ, Noort Mv M, Strous GJ, Clevers HC: Wnt signals are transmitted through n-terminally dephosphorylated beta-catenin. EMBO Rep 2002;3:63-68.
41. Hendriksen J, Fagotto F, van der Velde H, van Schie M, Noordermeer J, Fornerod M: Ranbp3 enhances nuclear export of active (beta)-catenin independently of crm1. J Cell Biol 2005;171:785-797.
42. Playford MP, Bicknell D, Bodmer WF, Macaulay VM: Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proc Natl Acad Sci U S A 2000;97:12103-12108.
43. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002;108:837-847.
44. Weston CR, Davis RJ: Signal transduction: Signaling specificity - A complex affair. Science 2001;292:2439-2440.
45. Harwood AJ: Regulation of gsk-3: A cellular multiprocessor. Cell 2001;105:821-824.
46. Frame S, Cohen P, Biondi RM: A common phosphate binding site explains the unique substrate specificity of gsk3 and its inactivation by phosphorylation. Mol Cell 2001;7:1321-1327.
47. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z: Phosphorylation of beta-catenin by akt promotes beta-catenin transcriptional activity. J Biol Chem 2007;282:11221-11229.
48. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, Mishina Y, Li L: Bmp signaling inhibits intestinal stem cell self-renewal through suppression of wnt-beta-catenin signaling. Nat Genet 2004;36:1117-1121.
49. Zhao J, Yue W, Zhu MJ, Sreejayan N, Du M: Amp-activated protein kinase (ampk) cross-talks with canonical wnt signaling via phosphorylation of -catenin at ser 552. Biochem Biophys Res Comm 2010;395:146-151.
50. Gao Y, Zhou Y, Xu A, Wu D: Effects of an amp-activated protein kinase inhibitor, compound c, on adipogenic differentiation of 3t3-l1 cells. Biol Pharm Bull 2008;31:1716-1722.
51. Gilot D, Giudicelli F, Lagadic-Gossmann D, Fardel O: Akti-1/2, an allosteric inhibitor of akt 1 and 2, efficiently inhibits camkialpha activity and aryl hydrocarbon receptor pathway. Chem Biol Interact 2010;188:546-552.
52. Anderson GJ, Darshan D: Small-molecule dissection of bmp signaling. Nat Chem Biol 2008;4:15-16.
53. Khosla S: Minireview: The opg/rankl/rank system. Endocrinology 2001;142:5050-5055.
54. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T: Activation of amp kinase and inhibition of rho kinase induce the mineralization of osteoblastic mc3t3-e1 cells through endothelial nos and bmp-2 expression. Am J Physiol Endocrinol Metab 2009;296:E139-146.
55. Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R: Beta-catenin and bmp-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem 2005;94:403-418.
56. Rong S, Zhao X, Jin X, Zhang Z, Chen L, Zhu Y, Yuan W: Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the wnt/-catenin pathway. Cell Physiol Biochem 2014;34:2049-2060.